The fact that EGFR seems to be implicated in tumor resistance to chemo/radiotherapy via activation of DNA DSB repair pathways such as non-homologous end joining (NHEJ) mechanism might also explain the reversibility of Rck-induced DNA-damage (Rodemann et al., 2007). The gene discussed is EGFR; the disease is neoplasm.